Analyst Reco. ImpediMed Limited

Equities

Delayed Australian S.E. Other stock markets 04:31:21 08/05/2024 BST			5-day change	1st Jan Change
0.079 ^AUD	-1.25%		-1.25%	-45.52%

04-30	ImpediMed's Qaurterly Revenue Rises in Fiscal Q3; Shares Fall 8%	MT
04-30	Transcript : ImpediMed Limited, Q3 2024 Earnings Call, Apr 30, 2024

Ord Minnett Starts ImpediMed at Speculative Buy, Price Target is AU$0.16	04-17	MT
ImpediMed Limited Announces Current Data Support Early Detection and Intervention to Reduce Rates of Breast Cancer Related Lymphedema	26/10/22	CI

No results for this search